Cartesian Therapeutics RNAC
NASDAQ RNAC
$6.18 -0.23 (-3.59%)
At close: Oct 23, 2026 · 4:00 PM EDT

Cartesian Therapeutics (RNAC) Cash & Current Investments (2015 - 2026)

Updated

Cartesian Therapeutics (RNAC) posted Cash & Current Investments of $147.61 million for Q2 2026, down 7.9% from $160.32 million a year earlier but up 24.4% from the prior quarter.

Analysis

Cartesian Therapeutics (RNAC) Cash & Current Investments (2015 - 2026) Analysis & Trends

At the end of FY2025, Cartesian Therapeutics' Cash & Current Investments came in at $125.14 million, down 41.1% from FY2024.

  • Annual Cash & Current Investments shows a five-year compound annual growth rate of -2.0% (FY2020 to FY2025).
  • In prior years, Cartesian Therapeutics' Cash & Current Investments was $212.61 million in FY2024 (+176.4%), $76.91 million in FY2023 (-42.9%), $134.6 million in FY2022 (+5.1%) and $128.06 million in FY2021 (-7.7%).
  • Quarterly Cash & Current Investments has run from a low of $76.91 million in Q4 2023 to a high of $219.2 million in Q3 2024 over five years.
  • On a year-over-year basis, Cash & Current Investments has declined in each of the last four quarters, with growth averaging 49.0% over the last eight quarters.
  • The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q4 2024, with growth of 176.4%; the weakest was Q3 2023, with a decline of 45.6%.
  • According to Business Quant data, Cash & Current Investments for the three prior quarters was $118.64 million (Q1 2026), $125.14 million (Q4 2025) and $143.38 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 Cartesian Therapeutics 185.63 Mn -349.14 Mn - 147.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 147.61 Mn
Mar 31, 2026 118.64 Mn
Dec 31, 2025 125.14 Mn
Sep 30, 2025 143.38 Mn
Jun 30, 2025 160.32 Mn
Mar 31, 2025 180.43 Mn
Dec 31, 2024 212.61 Mn
Sep 30, 2024 219.20 Mn
Jun 30, 2024 87.23 Mn
Mar 31, 2024 103.42 Mn
Dec 31, 2023 76.91 Mn
Sep 30, 2023 79.60 Mn
Jun 30, 2023 112.03 Mn
Mar 31, 2023 125.93 Mn
Dec 31, 2022 134.60 Mn
Sep 30, 2022 146.44 Mn
Jun 30, 2022 142.06 Mn
Mar 31, 2022 117.43 Mn
Dec 31, 2021 128.06 Mn
Sep 30, 2021 138.66 Mn
API Access

Cartesian Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=RNAC&period=max&api_key=YOUR_API_KEY